TEST BANK FOR PHARMACOLOGY: A PATIENT-CENTERED NURSING PROCESS
APPROACH 10TH EDITION BY LINDA E. MCCUISTION, KATHLEEN VULJOIN
DIMAGGIO, MARY B. WINTON, JENNIFER J. YEAGER ||COMPLETE CHAPTERS 1-
55 WITH ACCURATE ANSWERS|| COMPLETE GUIDE A+
, TABLE OF CONTENTS
UNIT 1: INTRODUCTION TO PHARMACOLOGY ........................................................................ 4
CHAPTER 01: THE NURSING PROCESS AND PATIENT-CENTERED CARE ................................. 4
CHAPTER 02: DRUG DEVELOPMENT AND ETHICAL CONSIDERATIONS ................................ 12
CHAPTER 03: PHARMACOKINETICS, PHARMACODYNAMICS, AND PHARMACOGENETICS .. 23
CHAPTER 04: PHARMACOGENETICS .................................................................................. 44
CHAPTER 05: COMPLEMENTARY AND ALTERNATIVE THERAPIES ....................................... 48
CHAPTER 06: PEDIATRIC CONSIDERATIONS....................................................................... 56
CHAPTER 07: GERIATRIC CONSIDERATIONS ...................................................................... 65
CHAPTER 08: DRUGS OF ABUSE ........................................................................................ 73
UNIT 2: PHARMACOTHERAPY AND DRUG ADMINISTRATION ................................................ 81
CHAPTER 09: SAFETY AND QUALITY .................................................................................. 81
CHAPTER 10: DRUG ADMINISTRATION ............................................................................. 89
CHAPTER 11: DRUG CALCULATIONS .................................................................................. 97
UNIT 3: MAINTENANCE OF HOMEOSTASIS ......................................................................... 104
CHAPTER 12: FLUID VOLUME AND ELECTROLYTES........................................................... 104
CHAPTER 13: VITAMIN AND MINERAL REPLACEMENT ..................................................... 117
CHAPTER 14: NUTRITIONAL SUPPORT ............................................................................ 127
UNIT 4: AUTONOMIC NERVOUS SYSTEM DRUGS ................................................................ 138
CHAPTER 15: ADRENERGIC AGONISTS AND ANTAGONISTS ............................................. 138
CHAPTER 16: CHOLINERGIC AGONISTS AND ANTAGONISTS ............................................ 146
UNIT 5: CENTRAL AND PERIPHERAL NERVOUS SYSTEM DRUGS ........................................... 155
CHAPTER 17: STIMULANTS ............................................................................................. 155
CHAPTER 18: DEPRESSANTS ........................................................................................... 162
CHAPTER 19: ANTISEIZURE DRUGS ................................................................................. 171
CHAPTER 20: DRUGS FOR PARKINSON DISEASE AND ALZHEIMER DISEASE ...................... 181
CHAPTER 21: DRUGS FOR NEUROMUSCULAR DISORDERS AND MUSCLE SPASMS ............ 190
UNIT 6: MENTAL AND BEHAVIORAL HEALTH DRUGS .......................................................... 199
CHAPTER 22: ANTIPSYCHOTICS AND ANXIOLYTICS .......................................................... 199
CHAPTER 23: ANTIDEPRESSANTS AND MOOD STABILIZERS ............................................. 209
UNIT 7: PAIN AND INFLAMMATION MANAGEMENT DRUGS ............................................... 220
, CHAPTER 24: ANTIINFLAMMATORIES ............................................................................. 220
CHAPTER 25: ANALGESICS .............................................................................................. 229
UNIT 8: ANTIMICROBIAL DRUGS ........................................................................................ 239
CHAPTER 26: ANTIBACTERIALS ....................................................................................... 239
CHAPTER 27: ANTITUBERCULARS, ANTIFUNGALS, AND ANTIVIRALS ................................ 264
CHAPTER 28: PEPTIDES, ANTIMALARIALS, AND ANTHELMINTICS .................................... 276
UNIT 9: IMMUNOLOGIC DRUGS ......................................................................................... 280
CHAPTER 29: HIV- AND AIDS-RELATED DRUGS ................................................................ 280
CHAPTER 30: TRANSPLANT DRUGS ................................................................................. 286
CHAPTER 31: VACCINES .................................................................................................. 290
UNIT 10: ANTINEOPLASTICS AND BIOLOGIC RESPONSE MODIFIERS .................................... 296
CHAPTER 32: ANTICANCER DRUGS ................................................................................. 296
CHAPTER 33: TARGETED THERAPIES TO TREAT CANCER .................................................. 302
CHAPTER 34: BIOLOGIC RESPONSE MODIFIERS ............................................................... 307
UNIT 11: RESPIRATORY DRUGS .......................................................................................... 312
CHAPTER 35: UPPER RESPIRATORY DISORDERS .............................................................. 312
CHAPTER 36: LOWER RESPIRATORY DISORDERS ............................................................. 318
UNIT 12: CARDIOVASCULAR DRUGS ................................................................................... 327
CHAPTER 37: CARDIAC GLYCOSIDES, ANTIANGINALS, AND ANTIDYSRHYTHMICS ............. 327
CHAPTER 38: DIURETICS ................................................................................................. 337
CHAPTER 39: ANTIHYPERTENSIVES ................................................................................. 343
CHAPTER 40: ANTICOAGULANTS, ANTIPLATELETS, AND THROMBOLYTICS ...................... 351
CHAPTER 41: ANTIHYPERLIPIDEMICS AND PERIPHERAL VASODILATORS .......................... 361
UNIT 13: GASTROINTESTINAL DRUGS ................................................................................. 368
CHAPTER 42: GASTROINTESTINAL TRACT DISORDERS ..................................................... 368
CHAPTER 43: ANTIULCER DRUGS .................................................................................... 377
UNIT 14: EYE, EAR, AND SKIN DRUGS ................................................................................. 386
CHAPTER 44: EYE AND EAR DISORDERS .......................................................................... 386
CHAPTER 45: DERMATOLOGIC DISORDERS ..................................................................... 391
UNIT 15: ENDOCRINE DRUGS ............................................................................................. 397
CHAPTER 46: PITUITARY, THYROID, PARATHYROID, AND ADRENAL DISORDERS .............. 397
, CHAPTER 47: ANTIDIABETICS .......................................................................................... 408
UNIT 16: RENAL AND UROLOGIC DRUGS ............................................................................ 417
CHAPTER 48: URINARY DISORDERS................................................................................. 417
UNIT 17: REPRODUCTIVE AND GENDER-RELATED DRUGS ................................................... 424
CHAPTER 49: PREGNANCY AND PRETERM LABOR ........................................................... 424
CHAPTER 50: LABOR, DELIVERY, AND POSTPARTUM ....................................................... 433
CHAPTER 51: NEONATAL AND NEWBORN ....................................................................... 440
CHAPTER 52: WOMEN’S REPRODUCTIVE HEALTH ........................................................... 443
CHAPTER 53: MEN’S REPRODUCTIVE HEALTH ................................................................. 452
CHAPTER 54: SEXUALLY TRANSMITTED INFECTIONS ....................................................... 458
UNIT 18: SEXUALLY TRANSMITTED INFECTIONS ................................................................. 462
CHAPTER 55: ADULT AND PEDIATRIC EMERGENCY DRUGS .............................................. 462
UNIT 1: INTRODUCTION TO PHARMACOLOGY
CHAPTER 01: THE NURSING PROCESS AND PATIENT-CENTERED CARE
MULTIPLE CHOICE
1. THE NURSING PROCESS IS A FIVE-STEP DECISION-MAKING APPROACH THAT INCLUDES ALL OF THE
FOLLOWING STEPS, EXCEPT:
A. ASSESSMENT
B. PATIENT PROBLEM
C. PLANNING
D. RIGHT DRUG
ACCURATE ANS: D
THE NURSING PROCESS IS A FIVE-STEP DECISION-MAKING APPROACH THAT INCLUDES: 1) ASSESSMENT,
2) PATIENT PROBLEM, 3) PLANNING, 4) IMPLEMENTATION, AND 5) EVALUATION. “RIGHT DRUG” IS ONE
OF THE “SIX RIGHTS” OF MEDICATION ADMINISTRATION.
DIF: COGNITIVE LEVEL: UNDERSTANDING (COMPREHENSION)
TOP: NURSING PROCESS: PLANNING
,MSC: NCLEX: MANAGEMENT OF CARE
2. THE NURSE IS USING DATA COLLECTED TO SET GOALS OR EXPECTED OUTCOMES AND INTERVENTIONS
THAT
ADDRESS THE PATIENT’S PROBLEMS. WHICH STEP OF THE NURSING PROCESS IS THE NURSE APPLYING?
A. ASSESSMENT
B. PATIENT PROBLEM
C. PLANNING
D. EVALUATION
ACCURATE ANS: C
DURING THE PLANNING PHASE, THE NURSE USES THE DATA COLLECTED TO SET GOALS OR EXPECTED
OUTCOMES AND INTERVENTIONS WHICH ADDRESS THE PATIENT’S PROBLEMS. THE DATA WAS
COLLECTED DURING THE “ASSESSMENT” AND “PATIENT PROBLEM” STEPS. DURING THE “EVALUATION”
PHASE THE NURSE WOULD DETERMINE WHETHER THE GOALS AND OBJECTIVES SET DURING THE
PLANNING PHASE WERE MET.
DIF: COGNITIVE LEVEL: UNDERSTANDING (COMPREHENSION)
TOP: NURSING PROCESS: NURSING INTERVENTION
MSC: NCLEX: MANAGEMENT OF CARE
3. A 5-YEAR-OLD CHILD WITH TYPE 1 DIABETES MELLITUS HAS HAD REPEATED HOSPITALIZATIONS
FOR EPISODES OF HYPERGLYCEMIA. THE PARENTS TELL THE NURSE THAT THEY CAN’T KEEP TRACK OF
EVERYTHING THAT HAS TO BE DONE TO CARE FOR THEIR CHILD. THE NURSE REVIEWS MEDICATIONS,
DIET, AND SYMPTOM MANAGEMENT WITH THE PARENTS AND DRAWS UP A DAILY CHECKLIST FOR THE
FAMILY TO USE. THESE ACTIVITIES ARE COMPLETED IN WHICH STEP OF THE NURSING PROCESS?
A. ASSESSMENT
B. PLANNING
C. IMPLEMENTATION
D. EVALUATION
ACCURATE ANS: C
, THE IMPLEMENTATION PHASE IS THE PART OF THE NURSING PROCESS IN WHICH THE NURSE PROVIDES
EDUCATION, DRUG ADMINISTRATION, PATIENT CARE, AND OTHER INTERVENTIONS NECESSARY TO
ASSIST THE PATIENT IN ACCOMPLISHING ESTABLISHED MEDICATION GOALS.
DIF: COGNITIVE LEVEL: UNDERSTANDING (COMPREHENSION)
TOP: NURSING PROCESS: NURSING INTERVENTION
MSC: NCLEX: MANAGEMENT OF CARE
4. THE NURSE IS PREPARING TO ADMINISTER A MEDICATION AND REVIEWS THE PATIENT’S CHART
FOR DRUG ALLERGIES, SERUM CREATININE, AND BLOOD UREA NITROGEN (BUN) LEVELS. THE NURSE’S
ACTIONS ARE REFLECTIVE OF WHICH PHASE OF THE NURSING PROCESS?
A. ASSESSMENT
B. EVALUATION
C. IMPLEMENTATION
D. PLANNING
ACCURATE ANS: A
ASSESSMENT INVOLVES GATHERING INFORMATION ABOUT THE PATIENT AND THE DRUG, INCLUDING
ANY PREVIOUS USE OF THE DRUG.
DIF: COGNITIVE LEVEL: UNDERSTANDING (COMPREHENSION)
TOP: NURSING PROCESS: ASSESSMENT MSC: NCLEX: MANAGEMENT OF CARE
5. WHICH ASSESSMENT IS CATEGORIZED AS OBJECTIVE DATA?
A. A LIST OF HERBAL SUPPLEMENTS REGULARLY USED
B. LAB VALUES ASSOCIATED WITH THE DRUGS THE PATIENT IS TAKING
C. THE AGES AND RELATIONSHIP TO THE PATIENT OF ALL HOUSEHOLD MEMBERS
D. USUAL DIETARY PATTERNS AND FNOOD INTAKE
ACCURATE ANS: B
OBJECTIVE DATA ARE MEASURED AND DETECTED BY ANOTHER PERSON AND WOULD INCLUDE LAB
VALUES. THE OTHER EXAMPLES ARE SUBJECTIVE DATA.
